The Collagen Suprafamily: From Biosynthesis to Advanced Biomaterial Development
Autor: | Luis Delgado, Dimitrios I. Zeugolis, Anne Maria Mullen, Rufus Raghunath, Naledi Shologu, Aniket Kshirsagar, Abhay Pandit, Yves Bayon, Z Wu, Anna Sorushanova, Michael Raghunath |
---|---|
Přispěvatelé: | Teagasc Walsh Fellowship, Department of Agriculture, Food and the Marine, Ireland, Health Research Board, Science Foundation Ireland, European Regional Development Fund, College of Engineering and Informatics, National University of Ireland, Galway, Seventh Framework Programme, Horizon 2020 |
Rok vydání: | 2019 |
Předmět: |
collagen crosslinking
Materials science collagen self‐assembly Molecular Conformation Biocompatible Materials 02 engineering and technology Regenerative Medicine 010402 general chemistry 01 natural sciences Regenerative medicine Extracellular matrix chemistry.chemical_compound 571: Physiologie und verwandte Themen Biosynthesis Animals Humans General Materials Science Viable cell 2. Zero hunger Tissue Engineering Mechanical Engineering collagen characterization Biomaterial 021001 nanoscience & nanotechnology Recombinant Proteins Extracellular Matrix 0104 chemical sciences collagen biomaterials chemistry Biochemistry Mechanics of Materials Collagen 0210 nano-technology Protein Processing Post-Translational |
Zdroj: | Advanced Materials |
ISSN: | 0935-9648 |
DOI: | 10.1002/adma.201801651 |
Popis: | Collagen is the oldest and most abundant extracellular matrix protein that has found many applications in food, cosmetic, pharmaceutical, and biomedical industries. First, an overview of the family of collagens and their respective structures, conformation, and biosynthesis is provided. The advances and shortfalls of various collagen preparations (e.g., mammalian/marine extracted collagen, cell-produced collagens, recombinant collagens, and collagen-like peptides) and crosslinking technologies (e.g., chemical, physical, and biological) are then critically discussed. Subsequently, an array of structural, thermal, mechanical, biochemical, and biological assays is examined, which are developed to analyze and characterize collagenous structures. Lastly, a comprehensive review is provided on how advances in engineering, chemistry, and biology have enabled the development of bioactive, 3D structures (e.g., tissue grafts, biomaterials, cell-assembled tissue equivalents) that closely imitate native supramolecular assemblies and have the capacity to deliver in a localized and sustained manner viable cell populations and/or bioactive/therapeutic molecules. Clearly, collagens have a long history in both evolution and biotechnology and continue to offer both challenges and exciting opportunities in regenerative medicine as nature's biomaterial of choice. This work forms part of the Teagasc Walsh Fellowship (grant award number: 2014045) and the ReValueProtein Research Project (grant award number: 11/F/043) supported by the Department of Agriculture, Food and the Marine (DAFM) under the National Development Plan 2007–2013 funded by the Irish Government. This work has also been supported from the: Health Research Board, Health Research Awards Programme (grant agreement number: HRA_POR/2011/84); Science Foundation Ireland, Career Development Award Programme (grant agreement number: 15/CDA/3629); Science Foundation Ireland and the European Regional Development Fund (grant agreement number: 13/RC/2073); College of Engineering and Informatics, National University of Ireland Galway; EU FP7/2007-2013, NMP award, Green Nano Mesh Project (grant agreement number: 263289); EU FP7/2007-2013, Health award, Neurograft Project (grant agreement number: 304936); EU H2020, ITN award, Tendon Therapy Train Project (grant agreement number: 676338); National University of Singapore Tissue Engineering Programme (NUSTEP). The authors would like to thank M Doczyk, E Collin, W Daly, M Abu-Rub, D Thomas, S Browne, C Tapeinos, A Satyam and D Cigognini for their help in producing the figures. A.S., L.M.D., Z.W., N.S., A.K., R.N.R., A.M.M., A.P., M.R., and D.I.Z. have no competing interests. Y.B. is an employee of Sofradim Production – A Medtronic Company. D.I.Z would like to dedicate the manuscript to A.G.Z. who left and A.D.Z. who came peer-reviewed |
Databáze: | OpenAIRE |
Externí odkaz: |